Amesite Announces New Sales Win Under NurseMagic® Minimum Enterprise Pricing Model

The approximately 85% gross margin at the stated pricing level is an Amesite estimate, not a reported result.

Rhea-AI Summary

Amesite (AMST) announced a NurseMagic Enterprise sales win on September 24, 2026, under its minimum enterprise pricing model.

The model prices NurseMagic Enterprise at $1,099 per month for organizations with a patient census of up to 1,000 under a 12-month contract. Amesite estimates annual agreements at that level can generate approximately 85% gross margin. Previously announced milestones include a 2.4x sequential quarterly revenue increase, 63% revenue growth from NurseMagic Enterprise and an enterprise deployment with an approximately 2,700-patient census.

Positive

• Previously announced 2.4x sequential quarterly revenue increase

Negative

• None.

Argus 15 min delay 22 alerts

+19.23% vs previous close $1.24 last price 72.1x rel. volume Open Argus

Details

Market move: AMST +19.23% vs previous close. enterprise contract award

-13.0% Trough in 12 min

$1.01 $1.24 Day Range

$8.12M Market Cap

On Sep 24, the day this news came out, the latest delayed price for AMST is 19.23% above the previous close. Argus tracked a trough of -13.0% from its starting point during tracking. Our momentum scanner has recorded 22 alerts for this stock so far that day. The latest delayed price is $1.24. Relative volume is exceptionally heavy at 72.1x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

On Sep 24, the day this news came out, the latest delayed price for the stock is 5.8% below the prev...

Analysis

On Sep 24, the day this news came out, the latest delayed price for the stock is 5.8% below the previous close. The May 18 NurseMagic enterprise win established a 2,700-patient deployment, showing prior larger-census adoption alongside this smaller-organization pricing model; its historical 120.07% reaction does not establish how this announcement will trade.

Key Figures

Enterprise monthly price: $1,099 per month Patient census threshold: Up to 1,000 patients Contract term: 12 months +1 more

Enterprise monthly price

$1,099 per month

NurseMagic Enterprise minimum pricing model

Patient census threshold

Up to 1,000 patients

Organizations eligible for the stated monthly price

Contract term

12 months

Agreement term under the new pricing model

Estimated gross margin

Approximately 85%

Annual agreements at the stated pricing level

Historical Context

1 past event · Latest: May 18

1 event

1. May 18

   Enterprise customer win

   24h Move

   +120.1%

   Prior NurseMagic enterprise customer covered approximately 2,700 patients, establishing a larger-census deployment milestone.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

gross margin, emr

2 terms

gross margin financial

"approximately 85% gross margin"

Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.

View in glossary

emr technical

"replace their existing EMRs"

An electronic medical record (EMR) is a digital version of a patient’s paper chart used by a single clinic or hospital to store medical history, test results, prescriptions and treatment notes. For investors, EMR systems matter because they drive recurring software and service revenue, affect healthcare providers’ costs and efficiency, and carry regulatory, privacy and interoperability risks that can influence adoption, contract value and long‑term market growth.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company Estimates Agreements at New Pricing Level Can Generate Approximately 85% Gross Margin, Supporting Scalable Growth Across Post-Acute Care Organizations

DETROIT, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), an adaptive AI technology company and developer of the AI-native NurseMagic^® documentation platform and LynkMagic™ enterprise solutions, today announced a new sales win with its minimum enterprise pricing model, providing additional commercial validation for a model designed to serve post-acute care organizations across a broad range of operating sizes while supporting attractive unit economics and scalable revenue growth.

Under the new model, NurseMagic^® Enterprise is priced at $1,099 per month for organizations with patient census up to 1,000 under a 12-month contract. Amesite estimates annual agreements at this level provide approximately 85% gross margin, establishing meaningful contract value at smaller census levels while preserving greater revenue opportunity as deployment size increases.

The agreement builds on previously announced NurseMagic^® commercial milestones, including a 2.4x sequential quarterly revenue increase, 63% revenue growth from NurseMagic^® Enterprise and an approximately 2,700-patient census enterprise deployment, the Company’s largest announced deployment to date.

Amesite believes that the pricing model creates a repeatable commercial sale for smaller post-acute care organizations while allowing it to remain focused on larger multi-location and multi-state enterprises representing substantially greater census and revenue opportunities. Recent customer wins did not require customers to replace their existing EMRs or undertake a rip-and-replace technology implementation.

Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, “We made a deliberate decision to set a minimum enterprise price that works for Amesite and still delivers tremendous value to customers. At $1,099 per month for organizations with up to 1,000 census, we can serve smaller operators at attractive margins without building our business around small contracts. At the same time, our census-based pricing gives us significantly greater revenue opportunity as we win larger organizations. We believe this model enables us to generate returns on our technology investments.”

Sai Nittala, Amesite’s Head of Artificial Intelligence, said, “We designed this pricing structure to create a repeatable commercial model for smaller post-acute care organizations while maintaining attractive unit economics. Establishing a clear minimum enterprise price has helped us streamline sales and advance scalable revenue growth.”

Kalie Wortinger, Amesite’s Head of Engineering, said “Our recent sales wins have not required customers to replace their existing EMRs. As we expand the number of EMR environments NurseMagic^® supports, we can serve a broader portion of the post-acute care market. That interoperability reduces deployment friction and supports our ability to scale across customer environments.”

About Amesite Inc.

Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $1.5 trillion non-acute care segments. Its flagship product, NurseMagic^®, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic^® is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic^® meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages.

Forward-Looking Statement

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company and its business. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its business are set forth in the Company’s filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations

ir@amesite.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Amesite's NurseMagic Enterprise minimum price and contract term?

NurseMagic Enterprise is priced at $1,099 per month for organizations with a patient census of up to 1,000 under a 12-month contract.

Did Amesite's recent NurseMagic sales wins require replacing existing medical record systems?

No. Recent customer wins did not require customers to replace their existing electronic medical record systems or undertake a rip-and-replace technology implementation.